Anxiety & Depression Association of America

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Purpose

The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based intervention program.

Conditions

Depression
Alcoholism
Drug Abuse

Eligibility

Eligible Ages: Between 18 Years and 64 Years
Eligible Genders: All
Accepts Healthy Volunteers: No

Inclusion Criteria

English speaking - Diagnosis of Bipolar Disorder (BD) - Able to provide written informed consent

Exclusion Criteria

Cognitive impairments - Acutely psychotic - Medically unstable - History of schizophrenia spectrum disorder - History of mood incongruent psychotic symptoms - History of primary substance disorder - History of primary organic disease and/or dementia

Study Design

Phase: N/A
Study Type: Interventional
Allocation: N/A
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Masking: None (Open Label)

Arm Groups

Arm	Description	Assigned Intervention
Experimental Group Intervention Program	Patients diagnosed with Bipolar Disorder will receive therapy in a group setting of 4 to 12 male and female participants.	Behavioral: Interpersonal and Social Rhythm Therapy (ISRT) Interpersonal and Social Rhythm Therapy (ISRT) will be given once a week over a six week period for 55-60 minutes. ISRT emphasizes identifying and maintaining a regular routine in daily life. It includes addressing sleep and solving interpersonal concerns and conflicts by focusing on daily routine. Behavioral: Bipolar-Specific Cognitive Behavioral Therapy (CBT) Bipolar-Specific Cognitive Behavioral Therapy (CBT) will be given once a week over a six week period for 55-60 minutes.The therapy is directly focused on eliminating or managing specific problems experienced by people with Bipolar Disorder. As part of this intervention, participant's maladaptive thoughts, behaviors and emotions are identified followed by learning how to challenge negative thoughts and reframing into positive, more adaptive thoughts. Additionally, the intervention involves enhancing the participant's coping skills and the ability to view a situation more objectively. Behavioral: Mindfulness-Based Stress Reduction (MBSR) Mindfulness-Based Stress Reduction (MBSR) will be given once a week over a six week period for 55-60 minutes. MBSR is a structured intervention that utilizes mindfulness meditation to reduce suffering associated with physical and psychiatric illnesses. MBSR is nonreligious in nature and aims to encourage an enhanced awareness of moment-to-moment experience of noticeable mental processes. Behavioral: Psycho-education & Understanding Bipolar Medications Therapy Psycho-education & Understanding Bipolar Medications Therapy will be given once a week over a six week period for 55-60 minutes. Psycho-education & Understanding Bipolar Medications Therapy aims to provide psycho-education about Bipolar Depression as well as provide a platform for participants to address concerns about managing their illness. Issues such as managing symptoms, reducing relapses and hospitalizations as well as maintaining gains will be discussed

Recruiting Locations

More Details

Status: Recruiting
Sponsor: Emory University

Study Contact

Dorian Lamis, PhD
(404) 616-3533
dorian.lamis@emory.edu

Detailed Description

The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based intervention program. Groups will include topics such as interpersonal/social rhythm and mindfulness interventions, as well as interventions focused on understanding and changing thoughts to better cope with Bipolar Depression.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.